PCR test for COVID-19 in 1.5 hours

Conference "Continuity in oncohematology: from diagnosis to treatment"

Conference "Continuity in oncohematology: from diagnosis to treatment" Target audience: клинических и лабораторных генетиков, онкологов, онкогематологов, химиотерапевтов, патоморфологов, биоинформатиков, врачей КДЛ, биологов, научных сотрудников

We are waiting for you at Московский Клинический Научный Центр, ул. Новогиреевская, д.1, к.1 (1 корпус), конференц-зал

Dear colleagues, we invite you to take part in a scientific and practical conference with international participation "Continuity in hematology: from diagnosis to treatment".

The conference is devoted to the diagnosis and treatment of hemoblastosis.

The main criteria for the use of highly informative diagnostic methods, modern diagnostic and treatment capabilities, and the possibilities of cellular technologies will be considered.

Experts will discuss:

  • Current opportunities and future directions of molecular genetic and cytogenetic studies in patients with hemoblastosis
  • Automation of the sample preparation stage for conducting FISH research. Own experience
  • Follicular lymphoma: from the onset of the disease to the treatment of relapses 
  • Invasive mycoses in hematology: what you need to know for diagnosis and treatment
  • Evolution of approaches to the treatment of lymphoproliferative diseases
  • Molecular-adapted first-line therapy of diffuse B-cell large cell lymphoma
  • Application and prospects of FISH technology in the field of hematology in China
  • and other

Date: November 25, 2025
Time: 09:00 – 15:30

Official language: Russian. 

The event will be held in a hybrid format:

  • Moscow Clinical Research Center, Novogireevskaya str., 1, room 1 (1st building), conference hall (-1 floor)
  • Online broadcast on the site: mosgenetics.ru

We will be glad to see you!

GBUZ Moscow Clinical Scientific Center named after Loginov MHD